Prescription Drug Affordability Board Activity, June 2025

Prescription Drug Affordability Board Activity, June 2025 Activities Summary Colorado: Colorado’s next PDAB meeting will be held on August 22, 2025. Maryland: Maryland’s PDAB met on June 23 for updates about federal drug pricing and Maryland’s biotech and life sciences industry. Oregon: At its June 18 meeting, Oregon’s PDAB reviewed survey data and narrowed its…

[...]

Prescription Drug Affordability Board Activity, May 2025

Prescription Drug Affordability Board Activity, May 2025 Activities Summary Colorado: Colorado’s PDAB met on May 23 to approve the Data Submission Guide and begin rulemaking around an upper payment limit for Enbrel. Oregon: At its May 21 meeting Oregon’s PDAB discussed the timeline and process for affordability reviews and approved the generic drug report. One…

[...]

Prescription Drug Affordability Board Activity, April 17 – April 30, 2025

Prescription Drug Affordability Board Activity, April 17 – April 30, 2025 Activities Summary Colorado: Colorado’s PDAB updated the Colorado Prescription Drug Affordability Advisory Council on its progress on April 24, 2025. Conversation focused on gathering stakeholder feedback. Maryland: Maryland’s Prescription Drug Affordability Advisory Council met on April 28,2025 to hear an expert presentation about Drug…

[...]

Prescription Drug Affordability Board Activity through April 16, 2025

Prescription Drug Affordability Board Activity through April 16, 2025 Activities Summary Colorado: Colorado’s PDAB met on April 11, 2025, where it addressed an error in All-Payer Claims Database data and how it affected affordability review information for Enbrel, Cosentyx and Stelara. Maryland: Maryland’s PDAB did not meet in April. Oregon: Oregon’s PDAB met on April…

[...]

Prescription Drug Affordability Board Activity through March 31, 2025

Prescription Drug Affordability Board Activity through March 31, 2025 Activities Summary Colorado: Colorado’s PDAB cancelled its March meetings. Maryland: Maryland’s PDAB met on March 24, 2025 to begin a cost review of Farxiga and review feedback about updates to PDAB regulations. Oregon: Board members met on March 19, 2025, where they elected a subset of…

[...]